全国性研究显示SLE与控制人群存在显著死亡率差距,且与感染相关死亡增加有关
该研究基于匈牙利国家健康保险基金数据库,分析7888例成人SLE患者及匹配对照的发病率、患病率、死亡率和死因。SLE患者总体生存率显著低于一般人群,标准化死亡比在全部新发患者中为1.63、在接受治疗患者中为2.09,感染尤其是脓毒症对超额死亡率影响最大。
要点
- SLE患者总体生存率显著低于一般人群(P<0.001)。
- 标准化死亡比在全部新发患者中为1.63,在接受治疗患者中为2.09。
- 感染尤其是脓毒症对SLE超额死亡率影响最大。
核心结论
- 感染尤其是脓毒症对SLE超额死亡率有最大正向影响,提示SLE患者感染相关死亡风险增加。
研究设计与样本
- 基于匈牙利国家健康保险基金数据库的全国性回顾性、非干预性研究,共纳入7888例患者。
- 创建两个新发患者亚组:全部新发SLE患者组(4503例)和接受治疗SLE患者组(2582例,诊断后6个月内接受相关治疗)。
主要发现
- SLE人群中位年龄46.5岁,女性占85%。
- 发病率在全部新发SLE患者组为4.86/10万人,在接受治疗SLE患者组为2.78/10万人。
- 标准化死亡比在全部新发SLE患者组为1.63,在接受治疗SLE患者组为2.09。
- 两组总体生存率均显著低于一般人群(P<0.001),风险比分别为2.17和2.75。
- SLE患者癌症相关死亡较少见,但血液系统癌症和感染相关死亡更常见;脑血管疾病作为死因在SLE与对照间无显著差异。
临床怎么用
- 临床应重视SLE患者感染风险,尤其是脓毒症的预防、早期识别和管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of the present study was to analyse the incidence, prevalence, mortality and cause of death data of adult SLE patients and matched controls in a full-populational, nationwide, retrospective study. METHODS: This non-interventional study was based on database research of the National Health Insurance Fund of Hungary. A total of 7888 patients were included in the analyses, within which two subgroups of incident patients were created: the 'All incident SLE patients' group consisted of all incident SLE patients (4503 patients), while the 'Treated SLE patients' group contained those who received relevant therapy in the first 6 months after diagnosis (2582 patients). RESULTS: The median age of the SLE population was found to be 46.5 years (women 85%). The incidence rate was 4.86 and 2.78 per 100 000 inhabitants in the 'All incident SLE patients' and 'Treated SLE patients' groups, respectively. The standardized mortality ratio was 1.63 and 2.09 in the 'All incident SLE patients' and 'Treated SLE patients' groups, respectively. Overall survival was significantly lower (P < 0.001) in both groups than in the general population, with hazard ratio = 2.17 in the 'All incident SLE patients' group and hazard ratio = 2.75 in the 'Treated SLE patients' group. There was no significant difference between SLE and control deaths regarding cerebrovascular conditions as the cause of death. Generally, cancer-related deaths were less common, while haematological cancer and infection-related deaths were more common in SLE patients. CONCLUSION: Infections, especially sepsis, had the largest positive effect on top of the extra mortality of SLE. This highlights that SLE patients are at increased risk of infection-related death.
引用
- Kedves M, Kósa F, Kunovszki P, et al. Large-scale mortality gap between SLE and control population is associated with increased infection-related mortality in lupus. Rheumatology (Oxford). 2020. PMID: 32357240. doi:10.1093/rheumatology/keaa188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。